Historical and Clinical Experiences of Gene Therapy for Solid Cancers in China
AbstractBased on the theoretical and clinical development of modern medicines, gene therapy has been a promising treatment strategy for cancer and other diseases. The practice of gene therapy is nearly 27 years old, since the first authorized gene transfer study took place at the National Institute of Health in 1989. However, gene therapy was not readily adopted worldwide, until recently. Several gene therapy clinical trials have been carried out in China since 1998, and medical research in China has flourished. In this report, we review the history of gene therapy in China, focusing on treatment protocol, the administration cycle, dosage calculation, and the evaluation of therapeutic effects, in order to provide more information for the additional development of this promising treatment strategy. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Li, B.; Gao, N.; Zhang, Z.; Chen, Q.; Li, L.; Li, Y. Historical and Clinical Experiences of Gene Therapy for Solid Cancers in China. Genes 2017, 8, 85.
Li B, Gao N, Zhang Z, Chen Q, Li L, Li Y. Historical and Clinical Experiences of Gene Therapy for Solid Cancers in China. Genes. 2017; 8(3):85.Chicago/Turabian Style
Li, Bo; Gao, Ning; Zhang, Zhuang; Chen, Qian‐Ming; Li, Long‐Jiang; Li, Yi. 2017. "Historical and Clinical Experiences of Gene Therapy for Solid Cancers in China." Genes 8, no. 3: 85.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.